Abstract:TNF-alpha -related apoptosis-inducing ligand (TRAIL) is characterized by its preferential induction of apoptosis of tumor cells but not normal cells. Dendritic cells (DCs), besides their role as APCs, now have been demonstrated to exert cytotoxicity or cytostasis on some tumor cells. Here, we report that both human CD34(+) stem cell-derived DCs (CD34DCs) and human CD14(+) monocyte-derived DCs (MoDCs) express TRAIL and exhibit cytotoxicity to some types of tumor cells partially through TRAIL. Moderate expression of TRAIL appeared on CD34DCs from the 8th day of culture and was also seen on freshly isolated monocytes. The level of TRAIL expression remained constant until DC maturation. TRAIL expression on immature CD34DCs or MoDCs was greatly up-regulated after IFN-beta stimulation. Moreover, IFN-beta could strikingly enhance the ability of CD34DCs or MoDCs to kill TRAIL-sensitive tumor cells, but LPS did not have such an effect. The up-regulation of TRAIL on IFN-beta -stimulated DCs partially contributed to the increased cytotoxicity of DCs. Pretreatment of TRAIL-sensitive tumor cells with caspase-3 inhibitor could significantly increase their resistance to the cytotoxicity of IFN-beta -stimulated DCs. In contrast, NF-kappaB inhibitor could significantly increase the sensitivity of tumor cells to the killing by nonstimulated or LPS-stimulated DCs. Our studies demonstrate that IFN-beta -stimulated DCs are functionally cytotoxic. Thus, an innate mechanism of DC-mediated antitumor immunity might exist in vivo in which DCs act as effectors to directly kill tumor cells partially via TRAIL. Subsequently, DCs act as APCs involved in the uptake, processing, and presentation of apoptotic tumor Ags to cross-prime CD8(+) CTL cells.

Activation-Induced Cell Death and T Helper Subset Differentiation

The role of activation-induced cell death in the differentiation of T-helper-cell subsets

Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation

Study on the mechanism of activation induced cells death(AICD) in CD4~+ CD25~-T cells

Differential Roles of CD95L and TRAIL in Activation-Induced Cell Death of Cytotoxic T Lymphocytes (110.22)

Abundant C-Fas-associated Death Domain-Like Interleukin-1-converting Enzyme Inhibitory Protein Expression Determines Resistance of T Helper 17 Cells to Activation-Induced Cell Death.

Transmembrane TNF-α Promotes Activation-Induced Cell Death by Forward and Reverse Signaling

Resistance of Th17 Cells to Activation-Induced Cell Death (47.13)

Th17 Cells Undergo Fas-Mediated Activation-Induced Cell Death Independent of Ifn-Gamma

Lck is Required for Activation-Induced T Cell Death after TCR Ligation with Partial Agonists

Regulation of TRAIL Expression in T helper cells

Identifying Fas/Cd95 Non-Apoptotic Signaling Pathways Associated with T Cell Differentiation

Differential Regulation Of The Expression Of Cd95 Ligand, Receptor Activator Of Nuclear Factor-Kappa B Ligand (Rankl), Tnf-Related Apoptosis-Inducing Ligand (Trail), And Tnf-Alpha During T Cell Activation

Human CD8 T cells are susceptible to TNF-mediated activation-induced cell death

Developing and Activated T Cell Survival Depends on Differential Signaling Pathways to Regulate Anti-Apoptotic Bcl-x(L).

Involvement of Cellular Death in Trail/Dr5-Dependent Suppression Induced by Cd4(+)Cd25(+) Regulatory T Cells

Coupled feedback regulation of nuclear factor of activated T-cells (NFAT) modulates activation-induced cell death of T cells

Efficient T Cell Activation Via a Toll-Interleukin 1 Receptor-independent Pathway.

The Involvement Of Tnf-Alpha-Related Apoptosis-Inducing Ligand In The Enhanced Cytotoxicity Of Ifn-Beta-Stimulated Human Dendritic Cells To Tumor Cells

Activation-induced cell death in CAR-T cell therapy

Induction of Apoptosis by Anti-Cd3 Epsilon F(ab')2 in Antigen Receptor Transgenic Murine T Cells Activated by Specific Peptide.